Day 1 Morning: Peripheral Arterial & Acute Limb Ischaemia & Randomised Control Trial Update - Tuesday, 25th April
Venue: Kensington 1 / Livestream 1
Time: 08:00 - 13:00
Peripheral Arterial Consensus Update
Time: 08:00 - 09:40
| Anchor: | Roger Greenhalgh, London, United Kingdom |
| Moderators: | Andrew Holden, Auckland, New Zealand |
| Dittmar Boeckler, Heidelberg, Germany |
08:00 - 08:05
Edited Case: Is transradial the new approach for peripheral artery treatment
| Speaker: | Marianne Brodmann, Graz, Austria |
08:05 - 08:10
Audience Participation & Discussion
08:10 - 08:15
SFA Intervention - What DES data suggest are best
| Speaker: | Peter Schneider, San Francisco, United States |
08:15 - 08:20
Audience Participation & Discussion
08:20 - 08:25
Predictors of drug-coated balloon efficacy in femoropopliteal intervention: Insights from a patient-level pooled analysis
| Speaker: | Marianne Brodmann, Graz, Austria |
08:25 - 08:30
Audience Participation & Discussion
08:30 - 08:35
Edited Case: Optimising PTA following atherectomy in complex lower limb lesions: 12-month results of the DISSECT study
| Speaker: | Michael Lichtenberg, Arnsberg, Germany |
08:35 - 08:40
Audience Participation & Discussion
08:40 - 08:45
Directional atherectomy followed by drug-coated balloons to treat long, calcified femoropopliteal artery lesions: The REALITY study
| Speaker: | Thomas Zeller, Bad Krozingen, Germany |
08:45 - 08:50
Audience Participation & Discussion
08:50 - 08:55
Increasing supervised exercise therapy capacity for claudicates without additional vascular resource - The advantage of integrating public health services into vascular clinical pathways
| Speaker: | Naseer Ahmad, Manchester, United Kingdom |
08:55 - 09:00
Audience Participation & Discussion
09:00 - 09:05
Edited Case: MIMICS-3D 3-year results: Compelling clinical outcomes in complex patients and lesions
| Speaker: | Michael Lichtenberg, Arnsberg, Germany |
09:05 - 09:10
Audience Participation & Discussion
09:10 - 09:15
Five-year outcomes of drug-coated balloon treatment for femoropopliteal artery disease: DCB safety and effectiveness across real-world subgroups / reintervention patterns among patients with in-stent restenosis, long lesions, and chronic total occlusions
| Speaker: | Gunnar Tepe, Rosenheim, Germany |
09:15 - 09:20
Audience Participation & Discussion
09:20 - 09:25
A patient-level pooled analysis of drug-coated balloons versus bare metal stents for the treatment of symptomatic femoropopliteal disease
| Speaker: | Thomas Zeller, Bad Krozingen, Germany |
09:25 - 09:30
Audience Participation & Discussion
09:30 - 09:35
Challenging the status quo of SFA treatment
| Speaker: | Maarit Venermo, Helsinki, Finland |
09:35 - 09:40
Audience Participation & Discussion
Sponsored Education
Time: 09:40 - 10:10
Coffee Break
Time: 10:10 - 10:30
Acute Limb Ischaemia Consensus Update
Time: 10:30 - 10:40
| Anchor: | Roger Greenhalgh, London, United Kingdom |
| Moderator: | Gunnar Tepe, Rosenheim, Germany |
10:30 - 10:35
Podium First: Primary endpoint results of the STRIDE trial on thrombectomy for acute limb ischemia
| Speaker: | Sean Lyden, Cleveland, United States |
10:35 - 10:40
Audience Participation & Discussion
Sponsored Education
Time: 10:40 - 11:10
Randomised Controlled Trial Consensus Update
Time: 11:10 - 13:00
BASIL-2 Podium First Presentation
Time: 11:10 - 11:40
| Anchor: | Roger Greenhalgh, London, United Kingdom |
| Moderators: | Andrew Holden, Auckland, New Zealand |
| Dittmar Boeckler, Heidelberg, Germany |
11:40 - 11:45
Podium First: BEST CLI clinical trial update
| Speaker: | Matthew Menard, Boston, United States |
11:45 - 11:50
Podium First: BEST CLI quality of life data
| Speaker: | Alik Farber, Boston, United States |
11:50 - 13:00
Audience Participation & Roundtable Discussion
| Anchor: | Roger Greenhalgh, London, United Kingdom |
| Moderators: | Andrew Holden, Auckland, New Zealand |
| Dittmar Boeckler, Heidelberg, Germany |
Lunch Break
Time: 13:00 - 13:30